These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1337505)

  • 1. CDC advises on management of persons exposed to multiple-drug-resistant tuberculosis.
    Clin Pharm; 1992 Dec; 11(12):991, 994, 999. PubMed ID: 1337505
    [No Abstract]   [Full Text] [Related]  

  • 2. CDC issues guidelines for multidrug-resistant tuberculosis.
    Am Fam Physician; 1992 Oct; 46(4):1303-5. PubMed ID: 1329462
    [No Abstract]   [Full Text] [Related]  

  • 3. [Isolation of Mycobacterium tuberculosis with primary resistance to chemotherapeutic agents in patients with HIV infection].
    Sesma P; Esteban J; Gegundez MI; Manrique A; Espinosa P; Fernández-Guerrero ML
    Enferm Infecc Microbiol Clin; 1992; 10(7):416-20. PubMed ID: 1450261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistant Mycobacterium tuberculosis.
    Lim VK
    Med J Malaysia; 1993 Jun; 48(2):97-8. PubMed ID: 8350810
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tuberculosis: reemerging disease].
    Fiaccadori F
    Ann Ital Med Int; 1996; 11(3):167-9. PubMed ID: 8998261
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sensitivity of Mycobacterium tuberculosis in our environment].
    Unzaga MJ; Sota M; Melero P; Berdonces P; Ezpeleta C; Cisterna R
    Enferm Infecc Microbiol Clin; 1996; 14(6):399-400. PubMed ID: 8756225
    [No Abstract]   [Full Text] [Related]  

  • 7. Performance evaluation program for Mycobacterium tuberculosis drug-susceptibility testing process.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jan; 43(1):17-8. PubMed ID: 8272047
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycobacterial infections.
    Peloquin CA
    Pharmacotherapy; 1993; 13(6):634-9. PubMed ID: 8302690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of tuberculostatic-resistant Mycobacterium tuberculosis. Clinical aspects and impact on therapy and clinical course].
    Esteban J; Gegúndez MI; García-Corbeira P; Soriano F
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):415-9. PubMed ID: 8260512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada.
    Bozeman L; Burman W; Metchock B; Welch L; Weiner M;
    Clin Infect Dis; 2005 Feb; 40(3):386-91. PubMed ID: 15668861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of resistant mutants of Mycobacterium tuberculosis (MT) strains from different areas of Rumania. Bacteriological study--epidemiological aspects].
    Anastasatu C; Băicoianu S; Teodorescu A
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):212-22. PubMed ID: 4998673
    [No Abstract]   [Full Text] [Related]  

  • 13. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Jul; 41(28):507-9. PubMed ID: 1630427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary resistance of Mycobacterium tuberculosis].
    Barranquero Arola M; Gorritxo Gil B; Goiriena de Gandarias J
    Rev Sanid Hig Publica (Madr); 1984; 58(11-12):1107-15. PubMed ID: 6443589
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis drug resistance: summary report for 2003.
    Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496
    [No Abstract]   [Full Text] [Related]  

  • 16. The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population.
    Bifani P; Mathema B; Kurepina N; Shashkina E; Bertout J; Blanchis AS; Moghazeh S; Driscoll J; Gicquel B; Frothingham R; Kreiswirth BN
    J Infect Dis; 2008 Jul; 198(1):90-4. PubMed ID: 18498237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis and the expanding role of the laboratory.
    Kawamura LM; Desmond E
    MLO Med Lab Obs; 2005 Aug; 37(8):12-4, 16-8; quiz 20-1. PubMed ID: 16194009
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-resistant tuberculosis in New York City.
    Israel HL
    N Engl J Med; 1993 Jul; 329(2):134-5. PubMed ID: 8510694
    [No Abstract]   [Full Text] [Related]  

  • 19. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Influence of background factors, factors regarding the method of treatment and the course of the disease on the emergence of drug resistance].
    Yamamoto M; Nakamura H; Inagaki H
    Kekkaku; 1970 Oct; 45(10):349-57. PubMed ID: 4991618
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2004 Dec; 2(28):83-8. PubMed ID: 15557876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.